Form 4: Surmodics Director Lisa Wipperman Heine Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Director Lisa Wipperman Heine reports exercising stock options and selling shares of Surmodics Inc. on February 18, 2025.
Summary
- On February 18, 2025, Lisa Wipperman Heine, a director of Surmodics Inc. (SRDX), exercised stock options to acquire 2,640 shares of common stock at a price of $27.30 per share.
- Following the exercise, Ms. Heine sold 2,115 shares of common stock at a price of $34.09 per share.
- After these transactions, Ms. Heine beneficially owns 13,978 shares of Surmodics Inc.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company director, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track potential shifts in ownership and sentiment.
Stakeholder Impact
- The transactions may provide insights to shareholders regarding the director's view on the company's stock value.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of stock option exercise and sale of shares. |
| 02/20/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.